Clinical trials
Recruiting Thrombosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 10 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Regeneron Pharmaceuticals | 4 |
| American Thrombosis and Hemostasis Network | 2 |
| Boston Children's Hospital | 2 |
| Massachusetts General Hospital | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| All Natural Medicine Clinic, LLC | 1 |
| Brigham and Women's Hospital | 1 |
| Cayuga Biotech, Inc. | 1 |
| Columbia University | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombosis | 36 |
| Hemorrhage | 6 |
| Atrial Fibrillation | 5 |
| Hemostatic Disorders | 4 |
| Peripheral Arterial Disease | 4 |
| Venous Thromboembolism | 4 |
| COVID-19 | 3 |
| Hemophilia A | 3 |
| Pulmonary Embolism | 3 |
| Stroke | 3 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.